30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-Label Safety Switching Study
CNS Spectrums - United Kingdom
doi 10.1017/s1092852919000245
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Publisher
Cambridge University Press (CUP)